Answers are grounded in this paper and cite their sources.
Compares patient treatment satisfaction with onabotulinumtoxinA and topiramate for chronic migraine, suggesting differences in preferences.
To describe patient treatment satisfaction (PTS) with onabotulinumtoxinA versus topiramate for chronic migraine (CM).
No takes yet. Share an insight, caveat, or question.
Blumenfeld et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: